Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1997 Jun;56(6):341–342. doi: 10.1136/ard.56.6.341

Dyslipidaemia and rheumatoid arthritis

R SITUNAYAKE, G KITAS
PMCID: PMC1752397  PMID: 9227161

Full Text

The Full Text of this article is available as a PDF (60.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bacons P. A., Kitas G. D. The significance of vascular inflammation in rheumatoid arthritis. Ann Rheum Dis. 1994 Oct;53(10):621–623. doi: 10.1136/ard.53.10.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beynen A. C. Could chloroquine be of value in the treatment of hypercholesterolemia? Artery. 1986;13(6):340–351. [PubMed] [Google Scholar]
  3. Duncan M. R., Capell H. A. The use of antimalarials in combination with other disease modifying agents in RA--the British experience. Lupus. 1996 Jun;5 (Suppl 1):S50–S58. [PubMed] [Google Scholar]
  4. Ettinger W. H., Klinefelter H. F., Kwiterovitch P. O. Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids. Atherosclerosis. 1987 Feb;63(2-3):167–172. doi: 10.1016/0021-9150(87)90117-1. [DOI] [PubMed] [Google Scholar]
  5. Falkeborn M., Persson I., Adami H. O., Bergström R., Eaker E., Lithell H., Mohsen R., Naessén T. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol. 1992 Oct;99(10):821–828. doi: 10.1111/j.1471-0528.1992.tb14414.x. [DOI] [PubMed] [Google Scholar]
  6. Hokanson J. E., Austin M. A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996 Apr;3(2):213–219. [PubMed] [Google Scholar]
  7. Lakatos J., Hárságyi A. Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis. Clin Biochem. 1988 Apr;21(2):93–96. doi: 10.1016/s0009-9120(88)80094-8. [DOI] [PubMed] [Google Scholar]
  8. Law M. R., Wald N. J., Thompson S. G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994 Feb 5;308(6925):367–372. doi: 10.1136/bmj.308.6925.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lazarevic M. B., Vitic J., Mladenovic V., Myones B. L., Skosey J. L., Swedler W. I. Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin Arthritis Rheum. 1992 Dec;22(3):172–178. doi: 10.1016/0049-0172(92)90017-8. [DOI] [PubMed] [Google Scholar]
  10. Lazarevic M. B., Vitic J., Myones B. L., Mladenovic V., Nanusevic N., Skosey J. L., Swedler W. I. Antilipoprotein antibodies in rheumatoid arthritis. Semin Arthritis Rheum. 1993 Jun;22(6):385–391. doi: 10.1016/s0049-0172(05)80030-7. [DOI] [PubMed] [Google Scholar]
  11. Lip G. Y., Jones A. F. Lipoprotein (a) and vascular disease: thrombogenesis and atherogenesis. QJM. 1995 Aug;88(8):529–539. [PubMed] [Google Scholar]
  12. Monson R. R., Hall A. P. Mortality among arthritics. J Chronic Dis. 1976 Jul;29(7):459–467. doi: 10.1016/0021-9681(76)90086-2. [DOI] [PubMed] [Google Scholar]
  13. Mulherin D. M., Thurnham D. I., Situnayake R. D. Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis. Ann Rheum Dis. 1996 Nov;55(11):837–840. doi: 10.1136/ard.55.11.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Munro R., Morrison E., McDonald A. G., Hunter J. A., Madhok R., Capell H. A. Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis. 1997 Jun;56(6):374–377. doi: 10.1136/ard.56.6.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Myllykangas-Luosujärvi R. A., Aho K., Isomäki H. A. Mortality in rheumatoid arthritis. Semin Arthritis Rheum. 1995 Dec;25(3):193–202. doi: 10.1016/s0049-0172(95)80031-x. [DOI] [PubMed] [Google Scholar]
  16. Offermann M. K., Medford R. M. Antioxidants and atherosclerosis: a molecular perspective. Heart Dis Stroke. 1994 Jan-Feb;3(1):52–57. [PubMed] [Google Scholar]
  17. Ramsay L. E., Yeo W. W., Jackson P. R. Dietary reduction of serum cholesterol concentration: time to think again. BMJ. 1991 Oct 19;303(6808):953–957. doi: 10.1136/bmj.303.6808.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rantapä-Dahlqvist S., Wållberg-Jonsson S., Dahlén G. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis. 1991 Jun;50(6):366–368. doi: 10.1136/ard.50.6.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Raynauld J. P. Cardiovascular mortality in rheumatoid arthritis: how harmful are corticosteroids? J Rheumatol. 1997 Mar;24(3):415–416. [PubMed] [Google Scholar]
  20. Reilly P. A., Cosh J. A., Maddison P. J., Rasker J. J., Silman A. J. Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis. 1990 Jun;49(6):363–369. doi: 10.1136/ard.49.6.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
  22. Situnayake R. D., Thurnham D. I., Kootathep S., Chirico S., Lunec J., Davis M., McConkey B. Chain breaking antioxidant status in rheumatoid arthritis: clinical and laboratory correlates. Ann Rheum Dis. 1991 Feb;50(2):81–86. doi: 10.1136/ard.50.2.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stampfer M. J., Sacks F. M., Salvini S., Willett W. C., Hennekens C. H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991 Aug 8;325(6):373–381. doi: 10.1056/NEJM199108083250601. [DOI] [PubMed] [Google Scholar]
  24. Svenson K. L., Lithell H., Hällgren R., Selinus I., Vessby B. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch Intern Med. 1987 Nov;147(11):1912–1916. [PubMed] [Google Scholar]
  25. Svenson K. L., Lithell H., Hällgren R., Vessby B. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment. Arch Intern Med. 1987 Nov;147(11):1917–1920. [PubMed] [Google Scholar]
  26. Vathsala A., Weinberg R. B., Schoenberg L., Grevel J., Dunn J., Goldstein R. A., Van Buren C. T., Lewis R. M., Kahan B. D. Lipid abnormalities in renal transplant recipients treated with cyclosporine. Transplant Proc. 1989 Aug;21(4):3670–3673. [PubMed] [Google Scholar]
  27. Wallace D. J., Metzger A. L., Stecher V. J., Turnbull B. A., Kern P. A. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. Am J Med. 1990 Sep;89(3):322–326. doi: 10.1016/0002-9343(90)90345-e. [DOI] [PubMed] [Google Scholar]
  28. Wallberg-Jonsson S., Ohman M. L., Dahlqvist S. R. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol. 1997 Mar;24(3):445–451. [PubMed] [Google Scholar]
  29. Winyard P. G., Tatzber F., Esterbauer H., Kus M. L., Blake D. R., Morris C. J. Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis. 1993 Sep;52(9):677–680. doi: 10.1136/ard.52.9.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wållberg-Jonsson S., Uddhammar A., Dahlén G., Rantapä-Dahlqvist S. Lipoprotein(a) in relation to acute phase reaction in patients with rheumatoid arthritis and polymyalgia rheumatica. Scand J Clin Lab Invest. 1995 Jul;55(4):309–315. doi: 10.3109/00365519509104968. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES